Topics and Pearls
- Disease states such as atopic dermatitis, eczema, melanoma, psoriasis, and vitiligo
- Insights into topical and systemic therapies for skin disease
- Pearls for clinical practice management
- Pediatric dermatology and conference pearls
Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Interview Intersection: Expert Interviews From July 2024
Dermatology Times is recapping our top expert interviews from the month of July.
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
James Song, MD, shares a comprehensive guide to what is new, what is now, and what is next in AD treatment.
Exploring the Intersection of Permanent Makeup and Dermatology
Walter Liszewski, MD, shares insights into discrepancies between permanent makeup and decorative tattoos and which patients may benefit from permanent makeup.
VYNE's Iain Stuart, PhD, Talks Promise of VYN202 and BET Inhibition in Inflammatory and Psoriatic Disease
Iain Stuart, PhD, discusses VYN202's status and potential in psoriasis and immuno-inflammatory diseases.
Q&A: Mona Shahriari, MD, FAAD, Talks Multidisciplinary Care
Shahriari spoke about the importance of comprehensive care, collaborating with other specialists, and addressing psychosocial impact.
Addressing Sunscreen Safety: A Review of EWG’s 2024 Guide to Sunscreens
Adewole Adamson, MD, MPP, discusses the Environmental Working Group's 2024 Guide to Sunscreens and what clinicians should discuss with patients who express concerns with the headlines stemming from the report.
Q&A: Diagnostic and Therapeutic Pearls for Pediatric Dermatology
Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.
Meena Julapalli, MD: Finding and Prioritizing Joy in the Pediatric Dermatology Specialty
Julapalli discusses her SPD 2024 lecture, "Rediscovering Joy in our Lives and the Workplace," excitement for the future of pediatric dermatology, and more.
Nanette Silverberg, MD: Taking an Aggressive Treatment Approach to Progressive Vitiligo
Silverberg discusses her SPD 2024 lecture, "Approach to Progressive Vitiligo," the future vitiligo landscape, and more.
PODCAST: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD
In this episode, Albert Yan, MD, FAAP, FAAD, discusses his SPD 2024 session revolving around the helpful (or hindering?) role of artificial intelligence and chatbots in dermatology.
Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis
Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.
Timothy Caulfield, JD: Addressing Misinformation in the Health Care Space
Caulfield discusses his SPD 2024 lecture, "The Misinformation Crisis: How Did We Get Here and What Can We Do?"
Amy Paller, MD: Reviewing Top Insights for Clinical Practice From ESPD
Paller discusses her SPD 2024 lecture, "Updates from ISSVA, ESPD, and SID: What You Missed that Could Change Your Practice."
Lisa Swanson, MD, FAAD: The Current Topical Landscape for Pediatric Patients
Swanson discusses her SPD 2024 non-CME talk, expanding topical options for young patients, and more.
John Browning, MD: Medical Errors, Confirmation Bias, and Emerging Therapies in Pediatric Dermatology
Browning discusses his participation in an SPD 2024 panel discussion, the future of pediatric dermatology, and more.
PODCAST: Food Fight - Drs Treat and Oza Debate Eczema Triggers
In this episode, Vikash Oza, MD, and James Treat, MD, discuss their SPD 2024 session (debate) revolving around the topic: Does food trigger eczema?
Reflections on Decision-Making in Pediatric Dermatology
Smidt and Hunt offer insights on navigating pediatric dermatology decision-making, emphasizing learning from clinical scenarios and fostering a culture of feedback and improvement.
Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD
Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.
Phase 3 Ruxolitinib Study Shows Higher Rates of Adolescent Repigmentation
David Rosmarin, MD, shared his insights on the study in a Q&A with Dermatology Times.
Benzoyl Peroxide and Benzene: Latest findings from John Barbieri, MD, MBA, FAAD
Researchers behind the latest benzene studies found no increased cancer risk with use of products containing benzoyl peroxide.
Q&A: Real-World Insights on the VALUE Study for Chronic Inflammatory Skin Diseases
Diamant Thaçi, MD, PhD, shares insights on the data presented at the World Psoriasis & Psoriatic Arthritis (IFPA) Conference.
Innovative Melanoma Treatment Among NCInnovation's $5.2 Million Research Funding Recipients
Michelle Bolas and Rukiyah T. Van Dross-Anderson, PhD, discuss the significance of NCInnovations’ funding and the clinical impact of Van Dross-Anderson's research in patients with advanced melanoma.
Hematologic Safety of Ruxolitinib Cream in Children with Atopic Dermatitis
Linda Stein Gold, MD, reviews data presented at SPD and elaborates on study design, methodology, and results.
Emerging Therapeutic for Non-Segmental Vitiligo: Merck’s MK-6194
Iltefat Hamzavi, MD, discusses the REGINA 007 phase 2 trial evaluating MK-6194 for the treatment of non-segmental vitiligo.
Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.
Recent Videos
Related Content
